Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05827718 · ClinicalTrials.gov registry record · NA
Testing Promising Behavioral Economic Interventions to Promote Enrollment Diversity in Cardiovascular Cohort Studies
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 26,242
- Enrollment target
NCT05827718: Completed NA study, sponsored by University of Pennsylvania.
NCT05827718 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 26,242 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1770% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05827718, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 26,242 participants
- Enrollment target
Study Summary
Problem. Randomized clinical trials (RCTs) are the best way to determine if interventions are safe and effective. Usually only a small number of eligible patients enroll. This is because trials require people to consent to be enrolled and randomized. Black and Hispanic people are more likely to develop heart disease. They are also more likely to have risk factors for heart disease that are not controlled. Yet they are very under-represented in heart disease trials. This raises concerns about if trial results can be applied to the general population. Trial sponsors are required to enroll patients that reflect the racial and ethnic diversity of real-world people. Black and Hispanic people continue to enroll in trials at a lower rate. The goal of this study is to conduct a series of small randomized trials to test recruitment strategies to increase how many Black and Hispanic people enroll in heart disease clinical trials without diminishing trust. The investigators will test different recruitment strategies for participant enrollment in a few different areas. They will study the method of outreach, the way messages are framed, defaults, and enrollment incentives. They will run smaller recruitment strategy trials within larger parent trials (e.g. Penn Medicine Biobank cohort study). They will run a small recruitment strategy trial to test each approach and then include what they learned in the next small trial.
Primary Outcome
The number of Black and Hispanic patients who enroll in the cohort study, divided by the total number of Black and Hispanic patients attempted to be contacted for consideration of enrollment
Interventions
- BEHAVIORAL Method of Contact
- BEHAVIORAL Source of Contact
- BEHAVIORAL Framing Method (Appeal to Altruism or Social Proof
- BEHAVIORAL Incentive Structure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26,242 participants |
| Start Date | 2023-10-30 |
| Est. Completion | 2024-12-01 |
| Phase | NA |
What the finished NCT05827718 record still lists
NCT05827718 is an interventional study that assigns participants to a tested intervention. Its 26,242 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1770% higher).
The record links to 0 conditions, and to 4 interventions - of which Method of Contact is the first listed.
NCT05827718 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05827718 about?
NCT05827718 is a clinical study titled "Testing Promising Behavioral Economic Interventions to Promote Enrollment Diversity in Cardiovascular Cohort Studies". Problem. Randomized clinical trials (RCTs) are the best way to determine if interventions are safe and effective. Usually only a small number of eligible patients enroll. This is because trials require people to consent to be enrolled and randomized. Black and Hispanic people are more likely to deve...
What is the current status of trial NCT05827718?
This trial is currently completed. It is a NA study. The enrollment target is 26,242 participants. The study started on 2023-10-30. Estimated completion is 2024-12-01.
What interventions are being tested in trial NCT05827718?
The interventions under investigation include: Method of Contact (BEHAVIORAL), Source of Contact (BEHAVIORAL), Framing Method (Appeal to Altruism or Social Proof (BEHAVIORAL), Incentive Structure (BEHAVIORAL).
Who is sponsoring clinical trial NCT05827718?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05827718's enrollment target sits among peer trials
26,242 9th of 2000 higher than 1,992 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07300839 · 25,500 participants · Phase 3
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age
- NCT04678193 · 27,000 participants
COVID-19 Risk Assessment for Hospitalization Outcomes and Epidemiology Efficacy
- NCT03175302 · 25,240 participants
PREsurgical Cognitive Evaluation Via Digital clockfacEdrawing
- NCT04595201 · 25,000 participants
Clinical Follow-up of Pregnant Subjects Undergoing NIPT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI